AURA BIOPHARM AS
Under liquidation: 07/22/2026, Voluntary liquidation
Forskning og utvikling av farmasøytiske spesialpreparater.
Organization
- Chairman of the board
- OF
Olav Flaten1946
- Years since formation
- 10 years
- since Mar 30, 2016
- Type
- Limited company
- VAT registered
- No
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 300,000
- 1 share class
- Total number of shareholders
- 5
- 1 company, 4 persons
Financials
- Annual total result 2025
- -32,281
- NOK
- Total equity 2025
- -917,139
- NOK
Last update: Jul 22, 2026
Management
Board
| Name | Role | Shares |
|---|---|---|
OF 1946 | Chairman | 6.57 % indirectly |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
OF 1946 | Chairman | 6.57 % indirectly |
FN | - | 4.57 % directly |
AG | - | 4.45 % directly |
Last update: Jun 23, 2026
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 240,000 | 80 % | |
| Ordinary shares | 19,707 | 6.57 % | |
FN | Ordinary shares | 13,699 | 4.57 % |
AG | Ordinary shares | 13,362 | 4.45 % |
| Ordinary shares | 13,232 | 4.41 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total operating income | 0 | 0 | 0 | 0 |
Annual Total Result | -32,281 | -135,108 | -156,657 | -164,162 |
Total assets | 40 | 40,638 | 28,670 | 13,598 |
Total liabilities | 917,179 | 925,496 | 778,420 | 606,691 |
Total equity | -917,139 | -884,858 | -749,750 | -593,093 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total operating income | 0 | 0 | 0 | 0 |
Total operating costs | 32,234 | 135,009 | 156,279 | 163,682 |
Operating result | -32,234 | -135,009 | -156,279 | -163,682 |
Financial income/costs | -47 | -99 | -378 | -480 |
Profit before tax | -32,281 | -135,108 | -156,657 | -164,162 |
Total tax & extraordinary income/cost | 0 | 0 | 0 | 0 |
Annual Total Result | -32,281 | -135,108 | -156,657 | -164,162 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total fixed assets | 0 | 0 | 0 | 0 |
Total current assets | 40 | 40,638 | 28,670 | 13,598 |
Total assets | 40 | 40,638 | 28,670 | 13,598 |
Short term debt | 19,479 | 27,796 | 18,239 | 8,241 |
Long term debt | 897,700 | 897,700 | 760,182 | 598,449 |
Total liabilities | 917,179 | 925,496 | 778,420 | 606,691 |
Contributed capital | 293,203 | 293,203 | 293,203 | 293,203 |
Retained earnings | -1,210,342 | -1,178,061 | -1,042,953 | -886,296 |
Total equity | -917,139 | -884,858 | -749,750 | -593,093 |
Total equity and liabilities | 40 | 40,638 | 28,670 | 13,598 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises